Regen BioPharma Inc (RGBP) › Operating IncomeRegen BioPharma Inc (RGBP) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: -$319.8K2014: -$706.4K2015: -$1.98M2016: -$2.96M2017: -$2.51M2018: -$1.43M2019: -$756.8K2020: -$209.3K2021: -$200.8K2022: -$339.6K2023: -$687.0K2024: -$417.2K2025: -$338.5K-$338.5K2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$338.5K+18.9%2024-$417.2K+39.3%2023-$687.0K-102.3%2022-$339.6K-69.2%2021-$200.8K+4.1%2020-$209.3K+72.3%2019-$756.8K+46.9%2018-$1.43M+43.2%2017-$2.51M+15.1%2016-$2.96M-49.4%2015-$1.98M-180.2%2014-$706.4K-120.8%2013-$319.8K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share